Related Experiment Videos

Antisense inhibition of CD44 tailless splice variant in human articular chondrocytes promotes hyaluronan

H Jiang1, C B Knudson, W Knudson

  • 1Rush University Graduate School, Chicago, IL, USA.

Arthritis and Rheumatism
|November 17, 2001
PubMed
Abstract

Insights

Articular chondrocytes use a short CD44 variant to control matrix receptor function. This finding reveals how CD44 isoforms regulate chondrocyte behavior and matrix interactions.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Articular chondrocytes are key cells in cartilage maintenance.
  • CD44 is a matrix receptor involved in cell-matrix interactions.
  • Alternative splicing of CD44 generates isoforms with potentially different functions.

Purpose of the Study:

  • To investigate if articular chondrocytes utilize alternatively spliced CD44 variants.
  • To determine the role of a short intracellular tail CD44 isoform in modulating matrix receptor function.

Main Methods:

  • Cultured human articular chondrocytes with and without interleukin-1alpha (IL-1alpha).
  • Quantified CD44 exon 19 and 20 mRNA levels using RT-PCR.
  • Inhibited CD44 exon 19 mRNA with antisense oligonucleotides.
  • Assessed matrix assembly and hyaluronan internalization.

Main Results:

  • Human articular chondrocytes express CD44 mRNA variants with short (exon 19) and long (exon 20) intracellular tails.
  • IL-1alpha up-regulated both CD44 mRNA variants.
  • Inhibiting CD44 exon 19 enhanced hyaluronan internalization and reduced cell-associated matrices.

Conclusions:

  • Articular chondrocytes express a CD44 variant acting as a decoy receptor.
  • This CD44 isoform modulates the function of the primary matrix receptor.
  • Alternative splicing of CD44 plays a role in chondrocyte matrix regulation.

Related Concept Videos